Legal & General Group PLC I Bio, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.23 - $0.46 $4,067 - $8,134	-17,684 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$1.22 - $1.65 $6,143 - $8,309	-5,036 Reduced 22.17%	17,684 $27,000
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $2,755 - $6,117	2,335 Added 11.45%	22,720 $35,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.24 $14,091 - $30,060	13,420 Added 192.68%	20,385 $21,000
Q3 2020 Nov 13, 2020	SELL	$1.7 - $6.41 $1,224 - $4,615	-720 Reduced 9.37%	6,965 $14,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $6,685 - $18,905	7,685 New	7,685 $17,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.